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EssC: domain structures inform on the elusive translocation channel in the
Type VII secretion system
Martin Zoltner*, Wui M.A.V. Ng*, Jillian J. Money*, Paul K. Fyfe*, Holger Kneuper*, Tracy Palmer* and William N. Hunter*1
*School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.
The membrane-bound protein EssC is an integral component
of the bacterial Type VII secretion system (T7SS), which is a
determinant of virulence in important Gram-positive pathogens.
The protein is predicted to consist of an intracellular repeat
of forkhead-associated (FHA) domains at the N-terminus, two
transmembrane helices and three P-loop-containing ATPase-type
domains, D1–D3, forming the C-terminal intracellular segment.
We present crystal structures of the N-terminal FHA domains
(EssC-N) and a C-terminal fragment EssC-C from Geobacillus
thermodenitrificans, encompassing two of the ATPase-type
modules, D2 and D3. Module D2 binds ATP with high affinity
whereas D3 does not. The EssC-N and EssC-C constructs are
monomeric in solution, but the full-length recombinant protein,
with a molecular mass of approximately 169 kDa, forms a
multimer of approximately 1 MDa. The observation of protomer
contacts in the crystal structure of EssC-C together with similarity
to the DNA translocase FtsK, suggests a model for a hexameric
EssC assembly. Such an observation potentially identifies the
key, and to date elusive, component of pore formation required
for secretion by this recently discovered secretion system.
The juxtaposition of the FHA domains suggests potential for
interacting with other components of the secretion system. The
structural data were used to guide an analysis of which domains
are required for the T7SS machine to function in pathogenic
Staphylococcus aureus. The extreme C-terminal ATPase domain
appears to be essential for EssC activity as a key part of the T7SS,
whereas D2 and FHA domains are required for the production of
a stable and functional protein.
Key words: ATPase, ESX-1, forkhead-associated domain,
membrane-bound protein, P-loop-containing domain, secretion
system.
INTRODUCTION
The specialized Type VII secretion system (T7SS) is employed
by many species of Gram-positive bacteria to translocate
proteins across the cell envelope. In the important pathogens
Mycobacterium tuberculosis and Staphylococcus aureus this
complex secretion apparatus is a major determinant of virulence
[1,2]. The composition of the T7SS and nature of secreted
substrates is surprisingly diverse across phyla [3]. However, a
characteristic of this secretion system is the presence of two
types of protein, the ESAT-6 (early secreted antigenic target
of 6 kDA)/EsxA family of virulence factors, which represent
the prototypical substrate, and a large integral membrane-bound
protein predicted to possess multiple ATPase-type domains at the
C-terminal region. These domains are related to the ATP hydrolase
DNA translocase FtsK (filamenting temperature-sensitive mutant
K) first identified in Escherichia coli [4] and the stage III
sporulation protein from Bacillus subtilis (called SpoIIIE [5]).
FtsK and SpoIIIE form oligomeric assemblies with an active site
created by subunit pairing where ATP hydrolysis is utilized to
induce conformational changes that drive molecular transport.
Extending from the conservation of EssC across species there
are additional strands of evidence to support a central role for
this type of ATPase in the T7SS. The FtsK/SpoIIIE orthologue
EccC5 is essential to form a stable T7SS membrane complex
in M. tuberculosis [6]. Furthermore, the homologous EssC in
S. aureus is required for the secretion of ESAT-6 proteins and
EssC-knockout mutants lose the ability to establish persistent
infections [2,3].
To investigate EssC, the key core component of this important
bacterial secretion system, we targeted the protein from the
thermophilic bacterium Geobacillus thermodenitrificans. The
full-length membrane-bound EssC was heterologously expressed
in E. coli and the purified detergent-solubilized protein formed
an oligomer. Bioinformatics analysis predicts two cytoplasmic
components for this 169 kDa integral membrane protein
(Figure 1). An N-terminal 26 kDa fragment (EssC-N) composed
of two forkhead-associated (FHA) domains, similar to the
S. aureus orthologue [7], is followed by two transmembrane
helices. The C-terminal segment carries three predicted ATPase-
like modules or domains, termed D1, D2 and D3. The crystal
structures of EssC-N and EssC-C, a C-terminal fragment
comprising D2 and D3 (EssC-C, approximately 60 kDa), were
determined exploiting single-wavelength anomalous diffraction
(SAD) methods applied to selenomethionine (SeMet) derivatives.
Analysis of the molecular packing in the crystal lattice of EssC-
C and structural comparisons with FtsK suggests a model for
the translocation channel, which has so far evaded definitive
identification.
While the present study was in progress, Rosenberg et al.
[8] published an analysis of the ATPase domains of the EssC
orthologue EccC, with an emphasis on the M. tuberculosis
system. In common with our approach, they included proteins
from thermophilic bacteria for analyses and this allows us to
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Figure 1 EssC topology and EssC-C structure
Cartoon representation of EssC-N (left) in rainbow colour gradient (N-terminus blue to C-terminus red), consisting of two FHA domains. In the topology cartoon of full-length EssC (middle) the
structurally characterized domains are drawn in the same colour scheme. Two transmembrane segments (grey cylinders) are predicted with the N-terminal 235 residue peptide, including EssC-N,
in the cytoplasm. Cartoon representation of EssC-C (right) in rainbow colour gradient (N-terminus blue to C-terminus red). The bound nucleotide analogue mant-ATP is drawn as sticks. The loop
connecting the two ATPase domains, the bound nucleotide, the P-loop and the swapped β9-segment feature are identified.
compare structures of similar EssC-C constructs of the D2–D3
combination. The comparison reveals a major conformational
difference involving D2 that might be linked to the function
of the transport system, and a minor perturbation in D3 that
correlates with a difference in ATP binding. Rosenberg et al.
[8] proposed that the ATPase domain D1 was auto inhibited by
the adjacent D2 domain and extended their analyses to include
yeast two-hybrid binding studies that indicated binding of the
ESAT-6 protein EsxB to EccC and, as will be discussed, a model
of oligomerization dependent on complex formation with EsxB.
Informed by our structural data on the G. thermodenitrificans
protein, we investigated the contributions that specific domains of
EssC might make to the T7SS of the related organism S. aureus.
MATERIALS AND METHODS
Cloning
The full-length gene for G. thermodenitrificans NG80-2 EssC
[Uniprot: A4IKE7, codon optimized for E. coli K12 (Genscript)]
was cloned into the NcoI/XhoI site of a modified pET27b vector
(Novagen) creating pET27bEssC. A construct to produce the N-
terminal EssC-N fragment (residues 1–196) was PCR amplified
from the full-length gene and cloned into the NcoI/XhoI site of
a modified pET27b vector (Novagen) creating pET27b EssC-
N. A construct to produce the C-terminal fragment EssC-C
(residues 966–1479) was cloned into the same vector. Both
plasmids produce an N-terminal hexahistidine-tagged protein
with a tobacco etch virus (TEV) protease cleavage site.
Full-length S. aureus essC (Uniprot: P0CO48) and the various
domain-deletion constructs (FHA, D23 and D3) were amplified
from genomic DNA (strain RN6390) and cloned into the
BglII/EcoRI sites of plasmid pRMC2 [9]. Haemagglutinin (HA)-
tagged variants of full-length essC and domain deletion constructs
D23 and D3 were amplified from the respective untagged
constructs and cloned into pRAB11 [10]. Primers used for cloning
purposes are listed in Supplementary Table S1. The integrity of
all constructs was verified by sequencing.
Recombinant protein production
The recombinant EssC-N protein was obtained by cultivating
freshly transformed E. coli BL21(DE3) pLysS in a 20 ml starter
culture of Luria–Bertani (LB) medium including 50 μg/ml kana-
mycin and 15 μg/ml chloramphenicol. A 5 ml volume of starter
culture was used to inoculate 1 litre of LB culture (total 4 litres)
including 1 mM magnesium chloride and 0.5 mM calcium
chloride and grown at 37 ◦C in 5 litre Erlenmeyer flasks. When the
D600 reached 0.6–0.8, expression was induced with 1 mM IPTG
(isopropyl-β-D-thiogalactopyranoside) and the culture was
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incubated overnight at 25 ◦C. The cells were harvested by
centrifugation (5000 g, 30 min, 4 ◦C) then resuspended in buffer
A (50 mM sodium phosphate, pH 7.8, 300 mM sodium chloride
10% glycerol) along with 1 mM DTT and a Mini Protease
inhibitor tablet (Roche). The cell/buffer A mixture was processed
in a French press (Thermo) and the lysed sample was passed
through a 0.45 μm filter and supplemented with 25 mM imidazole
ready for the first affinity chromatography purification step. A
1 ml CV (column volume) His-Trap HP column (GE Healthcare)
charged with Ni2 + was calibrated by four CV washes with buffer
B (50 mM sodium phosphate, pH 7.8, 25 mM imidazole, 300 mM
sodium chloride and 10% glycerol) after which the sample
was loaded and fractions were collected over a linear imidazole
concentration gradient (25–250 mM over 18 CV). Fractions
containing eluted EssC-N were combined and concentrated in a
spin concentrator (Sartorius) exchanging the buffer with buffer
A and the sample was incubated overnight with His-tagged
TEV protease (molar ratio of 1:20 TEV/recombinant protein) at
4 ◦C. The sample was passed through a His-Trap HP column
previously equilibrated with buffer A, to separate the desired
sample from non-cleaved protein and the TEV protease. Fractions
containing EssC-N were concentrated and further purified
using a Superdex75 GL10/300 size-exclusion chromatography
(SEC) column equilibrated with buffer C {10 mM Tris/HCl,
pH 7.8, 20 mM sodium chloride and 0.5 mM TCEP [tris-(2-
carboxyethyl)phosphine hydrochloride]}. Fractions containing
purified EssC-N were combined, concentrated to 20 mg/ml in
different buffers and used in crystallization trials.
An SeMet-labelled form of EssC-N was obtained using a
metabolic inhibition protocol [11]. For the starter culture freshly
transformed E. coli BL21(DE3) pLysS cells were grown in
50 ml of LB broth along with 50 μg/ml kanamycin and 15 μg/ml
chloramphenicol. The cells cultured for 14 h at 37 ◦C. The starter
culture was harvested, pelleted and washed with M9 medium and
used to inoculate 2 litres of M9 medium. The D600 reached 0.6–
0.8 after approximately 4 h and the culture was supplemented
with an amino acid stock containing 60 mg/l L-selenomethionine,
100 mg/l L-phenylalanine, L-lysine and L-threonine, and 50 mg/l
L-isoleucine, L-leucine and L-valine, then expression was induced
by addition of IPTG and the culture was incubated for 3 h at
37 ◦C. Purification of the SeMet-labelled EssC-N followed the
same protocol described for the native form of the protein.
To obtain EssC-C, similar protocols to those adopted for
production of EssC-N were used and following removal of the
His-tag the sample was dialysed against buffer A. For ATP-
binding and hydrolysis experiments, the final SEC step was
carried out in buffer D (50 mM Tris/HCl, pH 7.8, 100 mM
sodium chloride, 2 mM magnesium chloride and 0.5 mM TCEP).
SeMet-substituted EssC-C was obtained using the same metabolic
inhibition protocol outlined and the protein purified as for the
native sample.
The level of purity, mass of the recombinant proteins and that
full incorporation of SeMet had been achieved were determined by
matrix-assisted laser-desorption ionization–time-of-flight mass
spectrometry using an Applied Biosystems Voyager DE-STR
spectrometer (University of Dundee ‘Fingerprints’ Proteomics
Facility).
The preparation of full-length membrane-bound EssC followed
the same protocol used for EssC-C except that E. coli
LEMO21(DE3) cells were used, the culture medium contained
200 μM L-rhamnose and gene expression was induced with
400 μM IPTG [12]. Membranes were isolated by centrifugation
(150000 g, 60 min, 4 ◦C), after cells were disrupted in a French
press. The material was resuspended in buffer A and solubilized
with n-dodecyl-β-D-maltoside (DDM) at a protein/detergent mass
ratio of 1:3 for 2 h at 20 ◦C. Non-solubilized material was
removed by centrifugation and the resulting supernatant was
treated essentially as described above using buffers supplemented
with 0.03% (w/v) DDM and a Superdex 200 GL 30/100 column
(GE Healthcare) for SEC. The yields of EssC-N, EssC-C and
EssC were estimated on the basis of theoretical molar absorption
coefficients at 280 nm of 26930, 41510 and 149950 M− 1·cm− 1
respectively, calculated using VectorNTI (Invitrogen). Both SEC
columns used were calibrated with molecular mass standards
(thyroglobulin, 670 kDa; γ -globulin, 158 kDa; serum albumin,
67 kDa; ovalbumin, 44 kDa; myoglobin, 17 kDa; vitamin B12,
1 kDa).
S. aureus sample preparation and Western blotting
S. aureus strain RN6390 and the isogenic essC deletion variant
[3] were used for protein expression and secretion analysis. Cells
were grown overnight in tryptic soy broth (TSB) at 37 ◦C under
vigorous agitation, diluted 1:100 into fresh TSB medium and
growth was monitored by measuring the D600. Where necessary,
chloramphenicol, to a final concentration of 10 μg/ml, was added
for plasmid selection. Protein production was induced by addition
of anhydrotetracycline when the D600 of the culture reached 0.4.
Cells were grown until the culture reached a D600 of 2. Samples
were withdrawn and the cells were separated from the culture
supernatant by centrifugation at 2770 g. Supernatant samples
were passed through a 0.22 μm filter, directly mixed with an
appropriate amount of 4× NuPage LDS loading buffer and boiled
for 10 min. For whole cell fractions, pelleted cells were washed
with 1× PBS and normalized to a D600 of 2 in 1× PBS. Cells were
lysed by the addition of lysostaphin (Ambi) to a final concentration
of 50 μg/ml and incubated at 37 ◦C for 30 min. Samples were
mixed with an equal volume of 2× LDS loading buffer and boiled
for 10 min.
For the preparation of S. aureus membrane fractions, 10 ml of
D600 2 cells were pelleted and washed as described above and
resuspended in 1 ml of 1× PBS plus Mini Protease inhibitor
(Roche). Digestion of the cell wall was carried out using
lysostaphin and cells were broken by sonication. Intact cells were
removed by centrifugation (10000 g, 10 min, 4 ◦C) and membrane
fractions were prepared by ultracentrifugation (227000 g, 30 min,
4 ◦C). Membrane pellets were solubilized in 1× PBS and 0.5%
Triton X-100 and the supernatant was kept as the soluble protein
fraction. Protein concentration of the membrane and soluble
fractions was determined with the DCTM Protein Assay (Bio-
Rad Laboratories). For preparation of urea-washed membrane
fractions, broken cells were thoroughly mixed with an equal
volume of 8 M urea prior to ultracentrifugation. Membrane
pellets were washed with 1× PBS to remove residual urea and
resuspended as described above.
For Western blots, samples were mixed with LDS loading buffer
and boiled for 10 min prior to loading on Bis-Tris gels. Western
blots were performed according to standard methods with anti-
body dilutions as follows: anti-EsxA 1:2500, anti-EsxC 1:2000,
anti-EsaA 1:10000, anti-EssC 1:10000 and anti-TrxA 1:20000.
Binding of mant-ATP
A 1 mM stock solution of the fluorescent mant-ATP (2′/3′-
(N-methyl-anthraniloyl)-adenosine-5′-triphosphate triethylam-
monium salt; Jena Bioscience) was prepared in buffer D and
titrated with EssC-C. Fluorescence was monitored at 20 ◦C
using a LS44 spectrometer (PerkinElmer) with an excitation
wavelength of 350 nm (or 360–550 nm for the emission spectrum)
and an emission wavelength of 448 nm at a bandwidth of 5 nm.
Bound mant-ATP was displaced by titration with 100 mM ATP.
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Blue native polyacrylamide gel electrophoresis of EssC
Linear 4–12% gradient native Bis-Tris gels (Novex®, Life
Technologies) were used according to the manufacturer’s
protocol. Samples comprising 8 μg of purified EssC-C or 5 μg
of full-length EssC were loaded. Apoferritin (480 kDa), B-
phycoerythrin (242 kDa), lactate dehydrogenase (146 kDa), BSA
(66 kDa) and soyabean trypsin inhibitor (20 kDa) were used
as standard proteins. The EssC band was excised from the
BN-PAGE (blue native polyacrylamide gel electrophoresis) gel,
digested with trypsin and subjected to peptide mass fingerprinting
using matrix-assisted laser-desorption ionization–time-of-flight
mass spectrometry analysis (University of Dundee ‘Fingerprints’
Proteomics Facility).
Crystallographic analyses
Native EssC-N crystals, maximum dimension 0.2 mm, were
obtained in 2 days by sitting-drop vapour diffusion at 20 ◦C in
1 μl drops at the ratio of 1:1 protein solution (20 mg/ml EssC-N in
50 mM sodium phosphate, pH 7.8, 300 mM sodium chloride and
0.5 mM TCEP) to reservoir condition (0.2 M magnesium formate
and 20% w/v PEG3350). Isomorphous SeMet-labelled EssC-N
crystals were grown in the same fashion but with the protein
concentration halved. Crystals were harvested using glycerol or
a mineral oil cryo-protectant (LV-oil, MiTeGen), flash frozen
in liquid nitrogen and characterized in-house with a Rigaku
MicroMax 007HF generator equipped with VariMax VHF optic,
and a Saturn944 HG + charge-coupled device (CCD) detector.
Data were then collected, at − 173 ◦C, on beamline I04 at the
Diamond Light Source (DLS, Didcot, U.K.) with a Dectris Pilatus
6M-F detector. The data were indexed and merged using XDS [13]
and SCALA [14] respectively. The crystals displayed the space
group P212121. The structure could not be determined using the
native data; however, the SeMet-labelled crystal structure was
solved to 2.1 Å (1 Å=0.1 nm) using the SAD protocol of Auto-
Rickshaw [15]. A partial model of 63 residues was produced
during automated building using the program ARP_wARP [16].
FA values (the non-anomalous component of the Bijvoet pair)
were calculated using SHELXC [17]. The maximum resolution
for substructure determination and initial phase calculation was
set to 2.5 Å. Three out of four selenium atoms were found
using SHELXD [18]. Initial phases produced a CC (correlation
coefficient) of 0.29. The occupancy of all substructure atoms was
refined using the program BP3 [19]. Density modification, and
phase extension were performed using RESOLVE [20]. The CC
increased to 0.74 at 2.1 Å resolution and the model was extended
to 157 residues with BUCCANEER [21], as implemented in the
CCP4 suite of programs [22]. This resulted in Rwork and Rfree
of 0.25 and 0.31 respectively. This model was inspected, along
with electron density and difference density maps, adjusted and
extended to 184 residues using COOT [23] and then refined with
Refmac5 [24]. Translation/Libration/Screw (TLS) refinement
[25] in Refmac5 with multiple rounds of electron and difference
density map inspection, model manipulation and the inclusion of
water molecules and dual conformers completed the refinement.
Crystals of SeMet EssC-C, and the native complex with mant-
ATP were grown under oil at 20 ◦C. A volume of 1 μl of
protein solution (15 mg/ml EssC-C in 10 mM sodium phosphate,
pH 7.8, 20 mM NaCl, 10% glycerol, 0.5 mM TCEP and 2 mM
cysteine) was mixed with 1 μl of precipitant solution [0.1 M
sodium cacodylate, pH 6.3, 200 mM calcium acetate, 18% (w/v)
PEG300] in a Terasaki Microbatch plate (Molecular Dimensions)
and covered with silicone oil (Molecular Dimensions). For co-
crystallization, 2 mM mant-ATP and magnesium chloride were
added to the protein solution. Isomorphous orthorhombic crystals
formed after 2–3 weeks and grew up to 0.8 mm in length
over a further 2 weeks. The crystals were picked up in LV-oil
(MiTeGen), cooled in a stream of gaseous nitrogen at − 173 ◦C
then characterized in-house and diffraction quality was assessed.
X-ray data from SeMet-labelled EssC-C were collected on
BM30A at the European Synchrotron Radiation Facility (ESRF,
Grenoble, France) and data of nucleotide analogue-bound native
EssC-C at beamline I04 at Diamond Light Source, in each case
with an ADSC Q315r CCD detector. Data were processed using
XDS and SCALA. The crystals display space group I222 with
two polypeptides (labelled A and B, total 1034 residues) in the
asymmetric unit.
The EssC-C crystal structure was, as for EssC-N, solved
using the SAD protocol of Auto-Rickshaw. Analysis of the
data suggested that 3.5 Å was the appropriate resolution
for substructure determination and initial phase calculation.
Subsequently 31 out of 32 selenium atom positions were
identified and occupancy refined. Initial phases produced
a CC of 0.38. Density modification, phase extension and
two-fold non-crystallographic symmetry (NCS) averaging
were performed with RESOLVE. A partial model of 501
residues was made with HELICAP [26]. Model phases
were combined with the experimental phases and a further
round of density modification gave a CC of 0.63 at
2.8 Å. The model was extended to 947 residues with
BUCCANEER as implemented in the CCP4 suite. This resulted
in Rwork and Rfree values of 0.37 and 0.46 respectively. Inspection
of electron and difference density maps combined with model
building using COOT extended the model to 1004 residues.
Refinement with Refmac5, and employing strict NCS restraints
followed and reduced Rwork and Rfree values to 0.33 and 0.44
respectively. However, the N-terminal region, the D2–D3 linker
region and the interface where intermolecular symmetry contacts
occur were poorly defined.
Improved diffraction data were obtained from an isomorphous
crystal of the native EssC-C–mant-ATP complex. The partial
model of the SeMet protein was used for molecular replacement
with PHASER [27]. Two-fold map averaging using PARROT
[28] followed by model building using BUCCANEER generated
a model of 991 residues, which gave Rwork and Rfree values of 0.30
and 0.37. TLS refinement in Refmac5 with iterative rounds of map
inspection, model manipulation and the inclusion of nucleotide
ligands, water molecules, ethylene glycol and several side-chain
conformers completed the refinement. In one molecule there was
good density for the mant moiety of the ATP derivative, in the
other molecule the density for this part of the nucleotide ligand
was ambiguous and so ATP was modelled. In the early stages
of the analysis we included a Mg2 + ion positioned near the
ATP phosphates but it did not refine satisfactorily and so was
then removed. NCS restraints were applied at a domain level and
maintained throughout the refinement.
Crystallographic statistics are presented in Supplementary
Table S2. MOLPROBITY [29] and COOT were used to monitor
model geometry during refinement of both EssC-N and EssC-
C. Figures were prepared using PyMOL (Schro¨dinger LLC).
The DALI server was used to search the PDB for structural
homologues and structural superpositions were performed using
DALILITE [30]. Multiple sequence alignments were calculated
using ClustalW2 [31] and edited using ALINE [32]. Crystal
contact interfaces were analysed using PISA [33].
Computational modelling
The EssC transmembrane segments were predicted using
TMHMM v2.0 [34]. Homology models were generated using
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the one-to-one threading mode of the Phyre2 fold recognition
server [35]. A homology model of EssC-D1 (Ala643–Ile898) was
made on the basis of 231 residues in D2 and 278 residues in the
ATPase domain of the hexameric FtsK (PDB code 2IUU [36]),
and superimposed on the latter.
RESULTS AND DISCUSSION
Characterization of EssC and EssC-C
Recombinant EssC-C, the C-terminal residues 966–1479
comprising the two ATPase-like modules D2 and D3 (Figure 1),
was produced in E. coli and purified with a yield of 7 mg/l
culture. The protein, approximately 60 kDa, migrates in SEC
and BN-PAGE with apparent molecular masses of approximately
83 kDa and 65 kDa respectively, which is consistent with a
monomeric state. An additional higher-molecular-mass band
(180 kDa), accounting for approximately 5% of the total protein,
was observed in the BN-PAGE analysis suggestive of some
aggregation (Supplementary Figure S1).
An equilibrium binding constant of 0.94 +− 0.11 μM for the
ATP analogue mant-ATP with EssC-C was determined on the
basis of fluorescence measurements. The binding curve suggests a
stoichiometry of <1:1 (mant-ATP/EssC-C) as an excess of protein
was required to reach saturation. The mant-ATP fluorescence
observed when bound to EssC-C was quenched by addition of
ATP and the analogue was readily displaced (Supplementary
Figure S2).
Recombinant full-length 169 kDa EssC was detected in the E.
coli membrane fraction, solubilized and purified with yields of
typically approximately 10 μg/l bacterial culture. The purified
material migrated in a BN-PAGE experiment at an apparent
molecular mass of 1 MDa and the identity was confirmed by mass
fingerprinting analysis (Supplementary Figure S3). The observed
mass is consistent with the presence of a hexamer. Note also that a
multimeric form of EssC with a similar high molecular mass was
detected from S. aureus extracts in a recent cross-linking study
[37].
Structure of EssC-N
The EssC-N crystals, although of good appearance, displayed
diffraction that indicated the presence of multiple crystalline
components. It proved surprisingly difficult to determine the
structure, and numerous samples were tested before useable
data were recorded. Initial phases were derived from a SAD
experiment using SeMet-substituted protein and it was this model
that was subsequently refined. EssC-N consists of residues Met1–
Leu195 folded into a two-domain structure with each domain
representative of the β-sandwich FHA fold (Figure 1). Residues
Met1–Glu91 constitute domain FHA1, which is linked to FHA2
via a short dipeptide linker (Glu92 and Gln93). Seven residues are
missing from the model of FHA1 due to insufficient electron
density. These residues (at positions 19, 20, 53, 54, 80, 81 and 82)
are located on turns linking β-strands. FHA1 and FHA2 domains
consist of nine and 12 β-strands respectively with the domains
aligned almost perpendicular to each other. The domain–domain
contacts are mainly via van der Waals interactions between side
chains. These interactions involve residues on β1, β2, β8, β9
and the turns that link β1–β2 and β7–β8 on FHA1, with the
turns linking β15–β16, β17–β18 and β19–β20 on FHA2. A
pronounced feature at the domain–domain interface is Trp5 nestled
into a cavity formed by Leu162, Pro164 and Tyr165 (Figure 2). There
are van der Waals interactions formed between Cys12 and Leu14 of
Figure 2 Residues that contribute to the FHA1–FHA2 interface
The residues that contribute to the inter-domain interface are depicted in stick mode coloured
according to atom type (N blue, O red, S yellow) with grey C positions corresponding to FHA1,
cyan to FHA2 and orange for Gln93 that resides on the inter-domain linker. A water molecule is
shown as a blue sphere and potential hydrogen bonds as blue dashed lines.
FHA1 with Phe143 and Leu162 respectively on FHA2. Hydrogen-
bonding interactions also contribute to the domain alignments,
with a network of three glutamines (residues 3, 93, and 167)
and a water molecule interacting at one end of the interface.
In addition, Gln93 lies on the inter-domain linker section and
interacts with glutamines on each FHA domain, whereas at the
other end of the interface two hydrogen bonds involving main-
chain amide and carbonyl group link Thr10 and Tyr11 with Gly146
and Gln148 respectively to form a short section of antiparallel β-
sheet (Figure 2).
The most similar structural orthologue identified is also a twin-
FHA domain structure, namely the S. aureus EssC N-terminal
domains (PDB code 1WV3 [7]), which shares 15% sequence
identity. Superimposition of the twin domains, comprising some
172 Cα positions, results in an rmsd of 2.9 Å (Z-score 18)
and shows the alignment of the FHA domains with respect to
each other is conserved in the two structures (Supplementary
Figure S4). When individual domains are considered the rmsd
falls to 1.7 Å (Z-score 10.5) over 71 Cα positions and an rmsd
of 1.9 Å (Z-score 14.0) over 97 Cα positions for FHA1 and
FHA2 respectively. Although the identity of amino acids is poorly
conserved at the interface in general, the hydrophobic nature of the
side chains is maintained and a series of compensating changes
result in the same overall structure. For example, the Trp5:Leu162–
Pro164–Tyr165 configuration in G. thermodenitrificans Essc-N is
replaced by Ile5–Leu12–Tyr77–Gln75:Try158–Gly161 in the S. aureus
protein structure. The main differences between the structures are
that the FHA1 β6–turn–β7 segment of EssC-N is truncated by
eight residues and in FHA2, the β13–turn–β14 section extended
by five residues.
EssC-N also shares structural similarity with proteins involved
in phosphopeptide binding: at the level of single FHA domains
then alignments result in rmsd values of 1.5 Å (Z-score 9.7, 76
Cα positions) for FHA2 and 2.5 Å (Z-score 8.2, 78 Cα positions)
for FHA1 with the NMR-derived structure of Ki67 (PDB code
2AFF [38]).
The FHA domain was first identified in forkhead transcription
factors and subsequently in numerous proteins from both
prokaryotes and eukaryotes [39]. The proteins in which they are
found are implicated in diverse biological events including signal
transduction, transcriptional regulation and vesicular transport,
although the precise contribution of the FHA domains to these
processes remains elusive. In some examples the domain can bind
phosphothreonine-containing peptides so providing a mechanism
to link phosphorylation with direct protein–protein interactions
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[39]. However, as reported by Tanaka et al. [7], motifs common
to many FHA domains and residues implicated in the recognition
and binding of phosphothreonine, as exemplified by Ki67 are
absent from EssC-N.
We made numerous attempts, all unsuccessful, to identify
protein binding partners for the FHA domains using pull-down
and bacterial two-hybrid approaches (results not shown). The
only functional contribution we can assign to this EssC segment
at present is in making a contribution to producing a stable, active
protein (see below). It is intriguing, however, that the orientation
of the FHA domains with respect to each other is conserved in the
two structures discussed, in spite of a low sequence identify, and
this suggests a functional role for such a structural combination.
Structure of EssC-C
The crystal structure of EssC-C was phased from a SAD
experiment using an SeMet-substituted protein. A crystal of the
EssC-C–mant-ATP complex gave improved data and hence this
dataset was used to finalize the structure at 2.9 Å resolution
(Figure 1). The asymmetric unit consists of two EssC-C
polypeptides, labelled A and B, each resolved from Ala968 to the C-
terminal Glu1479. The polypeptide is composed of two homologous
P-loop ATPase-like modules or domains (D2 and D3), which are
connected by a linker (Gln1225–Ser1241). This domain structure is
dominated by a central β-sheet core of seven or eight strands
mainly aligned in parallel fashion and decorated with helices
on either side. In D2 the central parallel β-sheet is sandwiched
between α1–α2 and α3–α6 and in D3 between α10–α12 and α13–
α17. In D3 the core is extended with four strands β11, β12, β19
and β20. Strand β19 follows a sharp turn in the vicinity of the
potential ATP-binding site. In D2 the corresponding polypeptide
does not extend the core sheet but rather forms an extended
structure which we term the ‘β9-segment’ (Ile1171–Tyr1198) that
protrudes from the globular fold so that β9 (Gly1183–Lys1188) serves
to extend the central β-sheet of a symmetry-related molecule D2
domain through association with β8 (Thr1155–His1159) and β10
(Thr1195–Ile1197) (Supplementary Figure S5). A least-squares fit
of polypeptide A and B, over 457 Cα-atoms, results in an rmsd
of 2.1 Å. This relatively high value results from the different
positioning of the two domains with respect to each other, which
is facilitated by different conformations of the linker region.
Aligning individual domains for molecules A and B results in
an rmsd of 1.2 Å for D2 (231 Cα-atoms) and 0.6 Å for D3 (211
Cα-atoms).
The D2 domain
The initial structure of SeMet–EssC-C indicated that ATP was
present in the nucleotide-binding site of the D2 module even
though nucleotide had not been added during the crystallization.
The structure derived from crystals grown in the presence of
mant-ATP displayed additional density for the mant moiety in
one polypeptide (Supplementary Figure S6). ATP was included
in the other since there was no clear density for this mant moiety.
Aspects of protein–nucleotide recognition in EssC-C are similar
to the related Type IV pilus retraction (PilT) ATPase [40,41]. The
nucleotide binds in a polar cleft created on one side of the β-sheet
by several segments of the polypeptide fold. Both Walker A and B
type motifs [42] are evident (Supplementary Figure S7). The β3–
α1 loop encompasses the Walker A motif and also the N-terminal
dipole of this helix, the β4–α2 and β10–α9 segments and the
C-terminal part of β6 carries the Walker B motif. The Walker A
motif lysine [43], Lys1007, and the backbone amides of Gly1004,
Gly1006, Lys1007 and Thr1009 donate hydrogen bonds to α- and β-
phosphates (Supplementary Figure S6). The side chains of Lys1007
and Thr1009 form hydrogen bonds with β- and α-phosphate groups
respectively. The γ -phosphate participates in solvent-mediated
hydrogen bonds to the protein and direct interactions with side
chains of Ser1008, Asn1036 and Asp1105. Asp1105, in the Walker
B motif, is probably protonated to allow this association. The
adjacent residue in EssC-C D2 is Asn1106 rather than the canonical
acidic residue that primes a water molecule for nucleophilic attack
on the γ -phosphate [44]. This is unusual and, to the best of
our knowledge, no P-loop ATPase with such a variation of the
Walker B motif has been described. Indeed a similar substitution
of glutamine for the Walker B glutamate has been shown to abolish
ATPase activity but not ATP binding [45,46].
The adenine N6 donates a hydrogen bond to the main-chain
carbonyl of Ile1197, whereas N1 interacts with Gln1196 via a water
molecule. In similar fashion, N7 is linked to Thr1010 OG1 and
the Gly1006 carbonyl by another water molecule. Asp1207 holds the
ribose in place by a hydrogen bond with the O2’ hydroxy group.
The mant group is accommodated in a hydrophobic pocket formed
by Val1209 and Leu1210 on α9 and Ala1038 on α2 (Supplementary
Figure S6).
A comparison of D2 with the structure of the slightly longer
construct derived from the same protein (PDB code 4LYA [8]),
independently determined, shows that the structures, although
very similar, display a significant difference. In our structure
the segment between residues Ile1171–Tyr1198 extends away from
the core of the domain to form what we term the β9 segment
in an ‘out’ conformation. In PDB code 4LYA, this segment is
tucked back on the core structure forming two β-strands and a
tight turn between them, the ‘in’ conformation (Figure 3). The
first strand is positioned beside and interacts with the β5–α3
segment, whereas the second strand serves to extend the core
β-sheet interacting with β5 on one side then β10 on the other.
The turn is placed near the adenine-ribose components of the
nucleotide ligand. The construct used to generate PDB code
4LYA starts at residue 951, whereas ours is shorter and starts
at 961. The extended N-terminal structure in PDB code 4LYA
forms an edge of the adenine-binding pocket, and participates in
a number of interactions with the polypeptide that adopts the ‘in’
conformation. The presence of the ‘in’ conformation for the β9
segment and the N-terminal extension are, however, not essential
requirements for nucleotide binding since ATP or a derivative was
present in the ‘out’ conformation structure as well. Nevertheless,
the striking conformational adaptability shown by the β9 segment
hints at the possible structural changes that might occur as EssC
supports a motor transport process.
The D3 domain
Domains D2 and D3 share a sequence identity of 16% and
structural alignments within molecules A and B, of 194 and 179
Cα-atoms results in rmsd values of 2.8 and 2.6 Å respectively.
Major differences are that helices α4 and α8 of D2 are absent from
D3. The latter contributes to distinct polypeptide conformations
for the β9 segment, which extend the core sheet by contributing β9
and β19 respectively. The β9 segment of D2 then participates in
inter-molecular contacts as described above. The corresponding
region of the polypeptide in D3 is folded over the central β-
sheet adopting a conformation commonly observed in P-loop-
containing NTPases.
In our structure the D3 domain appears incapable of ATP
binding. Despite the inclusion of excess mant-ATP in the
crystallization conditions we only observe the ligand to bind
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Figure 3 A comparison of the EssC-C D2 ‘in’ and ‘out’ conformations
The least-squares overlay of D2 (black ribbon) with the equivalent domain of PDB code 4LYA (red
ribbon). The mant-ATP is shown in stick mode coloured according to atom type as in Figure 1.
Non-transparent regions highlight the different positioning of the β9-segment (labelled ‘in’ and
‘out’) and the extended N-terminus of PDB code 4LYA.
the D2 domain and this is consistent with binding data that
suggest a stoichiometry <1. However, Rosenberg et al. [8] report
a structure (PDB 4LYA) in which both D2 and D3 ATP-binding
sites are occupied. A comparison of the structures indicates that
conformational differences in the D3 P-loop produce a helical
structure (α10), which occludes the ATP-binding site (Figure 4).
The reasons for this difference are unclear, but comparisons
clearly indicate conformational pliability in this ligand-binding
site.
The Walker A motif is clearly recognizable in D3 (Gly1284–
Thr1291) (Supplementary Figure S7). However, in some EssC
orthologues, e.g. Staphylococcus spp., the third domain
lacks ATP-binding motifs entirely, even though homology
modelling predicts a similar fold. Although EssC from G.
thermodenitrificans and S. aureus share an overall sequence
identity of approximately 32%, the similarities vary depending on
specific domains, amounting to 65, 32 and 13%when comparing
the ATPase modules D1, D2 and D3 respectively. Very recently a
genomic survey revealed that there is unexpected diversity in S.
aureus EssC [47]. The EssC sequences were shown to fall into four
different groupings, with the sequence diversity largely confined
to the D3 module. Intriguingly, each of the four EssC variants was
associated with different candidate suites of secreted substrates,
implicating the D3 domain in substrate selectivity [47].
Site-directed mutagenesis to disable Walker A and B motifs
contributions to ATPase and nucleotide-binding activity in the
three domains of the B. subtilis EssC orthologue, called YukBA,
revealed that only the enzyme activity of D1 is essential for
secretion [48]. We speculate that D1 presents a well-conserved
ATPase activity that is essential for the mechanics of translocation
but that D2 and in particular D3 may have evolved to specialize
by interaction with particular cargoes for the distinct secretion
systems.
The D3 domain is essential for Type VII secretion
Informed by our structural models we carried out a truncation
analysis to determine which EssC domains might be essential
for T7SS function in a tractable model system. We designed
truncations to produce S. aureus EssC lacking ATPase D3 alone
(EssCD3), D2 and D3 (EssCD23) or the N-terminal FHA
domains (EssCFHA; Figure 5). Removal of the most C-terminal
ATPase module, D3, alone was sufficient to completely abolish
secretion of either EsxA or EsxC substrates, without affecting
the apparent stability or membrane integration of EssC (Figure 5
and Supplementary Figure S8). The deletion of D2 and D3 also
abolished substrate secretion, although in this case truncated EssC
was not detected in the membrane (Supplementary Figure S9).
Note that, it was necessary to provide this variant with a C-
terminal HA tag since it lacks the epitope that is recognized by the
EssC antiserum. Removal of the S. aureus EssC FHA domains
also resulted in no detectable secretion of EsxA or EsxC but
again no EssC variant could be detected by Western blotting. We
conclude that the extreme C-terminal ATPase domain is essential
for EssC activity possibly by interaction with cargo proteins and
that the presence of D2 and FHA domains are required for the
production of a stable protein.
Our findings contrast with a previous report that transposon
insertions at either codon 1279, which is close to the start of
encoding D3, or codon 721, which is part way through the
sequence encoding D1, did not significantly affect secretion of
EsxA or EsxB [2]. However, we could not rescue substrate
secretion even if we induced expression of the EssC truncates
with a high level of anhydrotetracycline (Supplemental Figure
S8), although overproduction of non-truncated EssC did enhance
substrate secretion suggesting that the amount of active EssC
in wild-type cells may be a limiting factor for activity of the
secretion system. Rosenberg et al. [8] suggest that the important
contribution that D3 makes to the T7SS is in binding directly
to a substrate, EsxB, and that this enforces a multimerization
to form the functional secretion apparatus. Although an attractive
model, again, our data contradict this in that full-length EssC from
S. aureus [37] and G. thermodenitrificans oligomerize in the
absence of EsxB. The data available suggest a complexity in
the function of EssC that is not yet fully understood.
Comparison with FtsK-ATPase and the generation of a hexameric
model
The conserved fold of the EssC-C D2 and D3 domains clusters
with the PilT class of ATPases [40], in particular FtsK. A structural
alignment of molecule A D2 with monomeric Pseudomonas
aeruginosa FtsK (PDB code 2IUT [36]) gives an rmsd of 2.2 Å
over 220 Cα-atoms and a Z-score of 22 with 20% sequence
identity (Figure 6). Molecule A domain D3 aligns with an rmsd of
2.8 Å for 220 Cα-atoms, a Z-score of 20, again with 20%
sequence identity. Notably, sequence comparison of domain EssC
D1 with FtsK reveals a significantly higher sequence identity
of 31%. Although the core of these structures overlay well,
the β9-segment feature of D2 is absent from monomeric and
hexameric forms of FtsK (PDB code 2IUU [36]). Rather, in this
part of the ATPase domain it is D3 which matches most closely
to FtsK. This is likely to be a result of the D2 ‘out’ conformation
described above. A significant difference is the presence of an
extended structure, or handle, in FtsK between α11 and β9, which
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Figure 4 A comparison of the P-loop conformations in D3 structures
Left: superimposition of EssC-C D3 (black ribbon) and the equivalent domain of PDB 4LYA (red ribbon). The bound ATP from PDB code 4LYA is depicted is similar fashion to the nucleotide in
Figure 1. Right: a magnified view of the nucleotide-binding site shows the different conformations of the P-loop.
Figure 5 Truncation analysis of EssC
(A) Schematic representation of the S. aureus EssC truncations constructed during the present study. (B) Whole cell (left panels) or supernatant (right panels) samples were prepared from S. aureus
strain RN6390 (wild-type) or the isogenic essC deletion strain harbouring pRMC2 alone (empty vector) or encoding the indicated EssC variants. Strains were cultured as described in the Materials
and methods section, and expression from pRMC2 derivatives was induced by addition of 25 ng/ml anhydrotetracycline. For each sample 11 μl of culture supernatant and 4 μl (EsxA) or 10 μl
(EsxC, TrxA) of cells adjusted to a D600 of 1 were loaded. Samples were separated on 15 % Bis-Tris gels and immunoblotted with antibodies raised against the Ess secreted substrates EsxA, EsxC or
the cytoplasmic control TrxA. (C) Volumes of 10 ml of cells from the same samples in (B) were adjusted to a D600 of 1, separated on 8 % Bis-Tris gels and blotted with an anti-EssC antibody (top
panel). The same samples were probed with an anti-EsaA antibody as a loading control (bottom panel).
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Figure 6 Sequence and structural alignment of EssC-C D2 and FtsK
(A) Amino acid sequence alignment with assigned elements of secondary structure. The FtsK handle (dashed box), the D2 β9-segment (grey box) and signature motifs, as described in [53], are
marked. The Walker A motif (red box), the invariant sequence pattern [A/G]XXXXGK[S/T], forms the P-loop that interacts with phosphate groups of the nucleotide and the Walker B motif (blue box)
residues (hhhhDE with h = hydrophobic residue). (B) Ribbon depiction showing the superimposition of EssC-C D2 (black) and the ATPase domain of P. aeruginosa FtsK (blue, PDB code 2IUT
[36]). The bound nucleotide analogue mant-ATP is drawn as sticks.
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Figure 7 Hexameric model of the three ATPase domains
The hexameric EssC-C model, with D2 (green) and D3 (orange), was generated by superimposition of D2 and the ATPase domain of hexameric FtsK (PDB code 2IUU [36]). EssC-C is drawn in
cartoon representation with the bound nucleotide shown as sticks. A homology model of D1 is depicted as a grey semi-transparent van der Waals surface representation. The tube-like structure,
formed by alignment of the three hexameric rings, is shown in side view (right).
corresponds to the positions of the EssC-C D2 α4–β6 and D3
α13–β16 loops. The FtsK handle (Pro570–Pro580) protrudes almost
20 Å from the C-terminal surface of the structure. In hexameric
FtsK this extension mediates contacts between subunits and helps
to create a stable dodecameric double ring assembly [36].
A model of a multimeric EssC-C assembly was constructed
by rigid body superimposition of D2 with hexameric FtsK and
no further manipulation (Figure 7). This model does not show
any steric clash for the position of the D3 domains, either with
other D3 or adjacent D2 domains. The resulting pore with an
inner diameter of approximately 30 Å would accommodate the
ESAT-6 family protein dimer, which is the prototypical T7SS
substrate [1]. Notably, the ESAT-6 family member EsxA from G.
thermodenitrificans (PDB code 3ZBH), like the homologue from
S. aureus [49] is a cylindrical structure displaying a polar,
primarily acidic, surface.
Conclusions
EssC and orthologues represent the only conserved membrane-
bound component of the T7SS. This protein therefore represents a
strong candidate as a component of the pore through which cargo
is transported. EssC possesses ATPase-like domains as found in
other proteins involved in transport processes and our data suggest
that, in similar fashion, the full-length EssC forms a hexameric
species. On the basis of comparison with the hexameric FtsK, we
have generated a model which we propose represents the cytosolic
entrance to the T7SS pore that would then be completed by the
transmembrane helices.
Recent studies on the T7SS in the related Mycobacterium
marinum and Mycobacterium bovis confirmed the critical role of
the EssC homologue EccC5, in formation of an ESX-5 membrane
complex that is functional for secretion [6]. Furthermore, on the
basis of the observation that the middle and C-terminal domains
of EccC5, equivalent to the D2 and D3 that we have studied,
are affected by limited proteolysis, it was concluded that these
domains are accessible and distant from the membrane. These
observations match our model and this part of EssC, perhaps
together with the FHA domains, might represent the hub for
binding other T7SS components, including substrates. For S.
aureus EssC it has been demonstrated that the first P-loop-
containing domain, D1, alone can provide a motive force for
secretion of EsxA and EsxB [2]. The remaining two domains
may then play an auxiliary or regulatory role. This is reminiscent
of VirB4, a soluble ATPase component of the Type IV secretion
system, which also displays similarities to the FtsK/SpoIII-type
family. VirB4 binds at the side of the Type IV core complex and
does not interact with the DNA cargo directly [50].
The intriguing structural similarity of EssC to DNA-
transporting ATPases, together with reports on the relevance of
T7SSs in DNA transfer [51,52], highlights the possibility that the
T7SS, like the Type IV secretion system, is a versatile secretion
system that might be involved in transport of protein and or DNA.
Future studies will address this important issue.
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